Kite Pharma logo

Kite Pharma

A company focused on delivering cure for cancer using engineered T cell therapy

3

Funding Rounds

$30.3m

Money raised

Overview

A company focused on delivering cure for cancer using engineered T cell therapy

Funding

Funding series

Funding Series Analysis

The company Kite Pharma has raised a total of $15.25m in funding over 3 rounds.

Key Insights:

  • Kite Pharma seed round: $250k
  • Kite Pharma Series A round: $15m
  • Kite Pharma Series A round May 2013: $15m
Kite Pharma logo
Kite Pharma seed round $250k
Kite Pharma logo
Kite Pharma Series A round $15m
Kite Pharma logo
Kite Pharma Series A round May 2013 $15m

Industries

Kite Pharma is active in the following industries:
  • Immunotherapy
  • Artificial Intelligence (AI)
  • Programming
  • Machine learning
  • Biopharmaceutical
  • Healthcare
  • Autoimmune disease
  • Biomedical engineering
  • Cancer
  • Technology
  • Oncology
  • Biology
  • Biotechnology
  • Internal medicine
  • Regenerative medicine
  • Medicine
  • Cell therapy
  • Tissue engineering
  • Engineering
  • Cancer immunotherapy
  • Allogeneic cell therapy

Subsidiaries

Kite Pharma operates through the following subsidiaries: